Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

Vibeke Strand, Roger A. Levy, Ricard Cervera, Michelle A. Petri, Helen Birch, William W. Freimuth, Z. John Zhong, Ann E. Clarke

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds